Department of Maxillofacial and Plastic Surgery, Bordeaux-Cedex France.
Int J Oral Maxillofac Surg. 2009 Dec;38(12):1289-97. doi: 10.1016/j.ijom.2009.07.018. Epub 2009 Aug 21.
Providing an acceptable quality of life for patients after reconstruction of mandibular segmental defects is challenging because the surgical techniques available have limitations. The authors evaluated two-stage mandibular reconstruction in rabbits and provide preliminary results in humans. 21 rabbits underwent bilateral segmental mandibulectomy and the defect was filled with methylmethacrylate. The methylmethacrylate was removed after 4 weeks and an iliac autograft performed on the right-hand side and an autogenous graft with hydroxyapatite and triphasic calcium phosphate (HA-betaTCP) on the left-hand side. Four patients with severe mandibular osteoradionecrosis underwent a two-stage reconstruction. No clinical or paraclinical complications were noted. Hematoxylin-eosin-saffron staining revealed an induced membrane lining the cavity of all samples with dense vascularity. Decalcified, undecalcified and histomorphometric analysis showed new bone formation in the biomaterial and the autograft. Calcium uptake was higher inside the new cortical bone, notably at sites with HA-betaTCP. CT scans at 6 months showed that two patients had a favorable outcome with cortico-cancellous bone. Microscopic and immunochemical analysis confirmed the experimental data. This study demonstrates the feasibility of mandibular reconstruction using the induced membranes technique. This technique is efficient, and the results would be better in non-irradiated patients with good general health.
为重建下颌骨节段性缺损的患者提供可接受的生活质量具有挑战性,因为现有的手术技术存在局限性。作者评估了兔的两阶段下颌骨重建,并提供了人类的初步结果。21 只兔子接受了双侧下颌骨节段切除术,并用甲基丙烯酸甲酯填充缺损。4 周后去除甲基丙烯酸甲酯,右侧进行髂骨自体移植,左侧进行羟基磷灰石和三相钙磷(HA-βTCP)自体移植。4 名严重下颌骨放射性骨坏死患者接受了两阶段重建。未观察到临床或临床前并发症。苏木精-伊红-藏红花染色显示所有样本的腔室内均有诱导膜,血管丰富。脱钙、未脱钙和组织形态计量学分析显示生物材料和自体移植物中有新骨形成。新皮质骨内的钙摄取量更高,尤其是在含有 HA-βTCP 的部位。6 个月的 CT 扫描显示,2 名患者的皮质松质骨有良好的结果。显微镜和免疫化学分析证实了实验数据。本研究证明了使用诱导膜技术进行下颌骨重建的可行性。该技术有效,在一般健康状况良好且未接受放疗的患者中效果更好。